
Richelle G. Shelton
Examiner (ID: 3810, Phone: (571)272-7960 , Office: P/2916 )
| Most Active Art Unit | 2916 |
| Art Unit(s) | 2916, 2902, 2912 |
| Total Applications | 2267 |
| Issued Applications | 2226 |
| Pending Applications | 0 |
| Abandoned Applications | 41 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10300215
[patent_doc_number] => 20150185215
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-02
[patent_title] => 'Cell-Based Assays For Post-Translational Enzyme Activity'
[patent_app_type] => utility
[patent_app_number] => 14/412454
[patent_app_country] => US
[patent_app_date] => 2013-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 26068
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14412454
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/412454 | Cell-Based Assays For Post-Translational Enzyme Activity | Jun 30, 2013 | Abandoned |
Array
(
[id] => 13076505
[patent_doc_number] => 10058306
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-28
[patent_title] => Method for obtaining fetal cells and fetal cellular components
[patent_app_type] => utility
[patent_app_number] => 14/410508
[patent_app_country] => US
[patent_app_date] => 2013-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 39
[patent_no_of_words] => 15993
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14410508
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/410508 | Method for obtaining fetal cells and fetal cellular components | Jun 23, 2013 | Issued |
Array
(
[id] => 10362840
[patent_doc_number] => 20150247845
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-03
[patent_title] => 'METHOD AND A SYSTEM FOR QUANTITATIVE OR QUALITATIVE DETERMINATION OF A TARGET COMPONENT'
[patent_app_type] => utility
[patent_app_number] => 14/409703
[patent_app_country] => US
[patent_app_date] => 2013-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 16832
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14409703
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/409703 | Method and a system for quantitative or qualitative determination of a target component | Jun 20, 2013 | Issued |
Array
(
[id] => 9121344
[patent_doc_number] => 20130288266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-31
[patent_title] => 'DETECTION OF A POSTTRANSLATIONALLY MODIFIED POLYPEPTIDE BY A BI-VALENT BINDING AGENT'
[patent_app_type] => utility
[patent_app_number] => 13/923618
[patent_app_country] => US
[patent_app_date] => 2013-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 28539
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13923618
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/923618 | DETECTION OF A POSTTRANSLATIONALLY MODIFIED POLYPEPTIDE BY A BI-VALENT BINDING AGENT | Jun 20, 2013 | Abandoned |
Array
(
[id] => 9121345
[patent_doc_number] => 20130288267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-31
[patent_title] => 'DETECTION OF A POLYPEPTIDE DIMER BY A BIVALENT BINDING AGENT'
[patent_app_type] => utility
[patent_app_number] => 13/923646
[patent_app_country] => US
[patent_app_date] => 2013-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 31737
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13923646
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/923646 | DETECTION OF A POLYPEPTIDE DIMER BY A BIVALENT BINDING AGENT | Jun 20, 2013 | Abandoned |
Array
(
[id] => 14425219
[patent_doc_number] => 10317408
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-11
[patent_title] => Method for quantifying immune cells in tumoral tissues and its applications
[patent_app_type] => utility
[patent_app_number] => 14/407698
[patent_app_country] => US
[patent_app_date] => 2013-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 19
[patent_no_of_words] => 8209
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 340
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14407698
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/407698 | Method for quantifying immune cells in tumoral tissues and its applications | Jun 13, 2013 | Issued |
| 13/883741 | BIOMARKERS AND THERAPEUTIC TARGETS FOR TREATING CARDIOMYOPATHIES AND CONGESTIVE HEART FAILURE | Jun 11, 2013 | Abandoned |
Array
(
[id] => 10292252
[patent_doc_number] => 20150177251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-25
[patent_title] => 'METHOD FOR DETECTING AND/OR ASSAYING ANNEXIN A3 FROM A MAMMAL IN BLOOD OR AT LEAST ONE DERIVATIVE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/405970
[patent_app_country] => US
[patent_app_date] => 2013-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 19138
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14405970
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/405970 | METHOD FOR DETECTINGAND/OR ASSAYING ANNEXIN A3 FROMA MAMMAL IN BLOOD OR AT LEAST ONE DERIVATIVE THEREOF | Jun 4, 2013 | Abandoned |
Array
(
[id] => 10292252
[patent_doc_number] => 20150177251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-25
[patent_title] => 'METHOD FOR DETECTING AND/OR ASSAYING ANNEXIN A3 FROM A MAMMAL IN BLOOD OR AT LEAST ONE DERIVATIVE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/405970
[patent_app_country] => US
[patent_app_date] => 2013-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 19138
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14405970
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/405970 | METHOD FOR DETECTING AND/OR ASSAYING ANNEXIN A3 FROM A MAMMAL IN BLOOD OR AT LEAST ONE DERIVATIVE THEREOF | Jun 4, 2013 | Abandoned |
Array
(
[id] => 10263251
[patent_doc_number] => 20150148248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-28
[patent_title] => 'MMP2 AS A PREDICTIVE BIOMARKER OF RESPONSE TO ANTIANGIOGENIC THERAPY AND SURVIVAL AFTER THERAPY IN CANCER PATIENTS'
[patent_app_type] => utility
[patent_app_number] => 14/402913
[patent_app_country] => US
[patent_app_date] => 2013-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9215
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14402913
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/402913 | MMP2 AS A PREDICTIVE BIOMARKER OF RESPONSE TO ANTIANGIOGENIC THERAPY AND SURVIVAL AFTER THERAPY IN CANCER PATIENTS | May 22, 2013 | Abandoned |
Array
(
[id] => 9785706
[patent_doc_number] => 20140302527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-09
[patent_title] => 'TARGET-SPECIFIC PROBE COMPRISING FERRITIN PROTEIN AND DETECTION FOR BIOMARKER USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/899830
[patent_app_country] => US
[patent_app_date] => 2013-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5405
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13899830
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/899830 | TARGET-SPECIFIC PROBE COMPRISING FERRITIN PROTEIN AND DETECTION FOR BIOMARKER USING THE SAME | May 21, 2013 | Abandoned |
Array
(
[id] => 9262648
[patent_doc_number] => 20130344577
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-26
[patent_title] => 'LIQUID CRYSTAL BASED SENSOR DEVICES FOR DETECTING TOXINS, BACTERIA AND THEIR ACTIVITIES'
[patent_app_type] => utility
[patent_app_number] => 13/893607
[patent_app_country] => US
[patent_app_date] => 2013-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 14088
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13893607
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/893607 | LIQUID CRYSTAL BASED SENSOR DEVICES FOR DETECTING TOXINS, BACTERIA AND THEIR ACTIVITIES | May 13, 2013 | Abandoned |
Array
(
[id] => 10256279
[patent_doc_number] => 20150141276
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-21
[patent_title] => 'IN VITRO METHOD FOR DIAGNOSIS OF ENDOMETRIOSIS'
[patent_app_type] => utility
[patent_app_number] => 14/400884
[patent_app_country] => US
[patent_app_date] => 2013-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5925
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14400884
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/400884 | IN VITRO METHOD FOR DIAGNOSIS OF ENDOMETRIOSIS | May 12, 2013 | Abandoned |
Array
(
[id] => 10240879
[patent_doc_number] => 20150125874
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-07
[patent_title] => 'TRANSIENT FLOW ASSAY'
[patent_app_type] => utility
[patent_app_number] => 14/398327
[patent_app_country] => US
[patent_app_date] => 2013-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7090
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14398327
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/398327 | TRANSIENT FLOW ASSAY | May 1, 2013 | Abandoned |
Array
(
[id] => 10477485
[patent_doc_number] => 20150362502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-17
[patent_title] => 'RAPID TEST FOR CELLULAR FIBRONECTIN'
[patent_app_type] => utility
[patent_app_number] => 14/391883
[patent_app_country] => US
[patent_app_date] => 2013-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7249
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14391883
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/391883 | RAPID TEST FOR CELLULAR FIBRONECTIN | Apr 10, 2013 | Abandoned |
Array
(
[id] => 12411729
[patent_doc_number] => 09970847
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-15
[patent_title] => Method for staining tissue
[patent_app_type] => utility
[patent_app_number] => 14/387730
[patent_app_country] => US
[patent_app_date] => 2013-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13564
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 211
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14387730
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/387730 | Method for staining tissue | Mar 25, 2013 | Issued |
Array
(
[id] => 15424457
[patent_doc_number] => 10545150
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-28
[patent_title] => Lung cancer molecular markers
[patent_app_type] => utility
[patent_app_number] => 14/388791
[patent_app_country] => US
[patent_app_date] => 2013-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 13
[patent_no_of_words] => 9757
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14388791
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/388791 | Lung cancer molecular markers | Mar 19, 2013 | Issued |
Array
(
[id] => 9134484
[patent_doc_number] => 20130295198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-07
[patent_title] => 'METHODS OF SCREENING CHEMOTHERAPEUTIC AGENTS AND TREATING CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/847292
[patent_app_country] => US
[patent_app_date] => 2013-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 14453
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13847292
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/847292 | Methods of screening chemotherapeutic agents and treating cancer | Mar 18, 2013 | Issued |
Array
(
[id] => 9737307
[patent_doc_number] => 20140273024
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'SYSTEM AND METHOD FOR DETERMINING RISK OF DIABETES BASED ON BIOCHEMICAL MARKER ANALYSIS'
[patent_app_type] => utility
[patent_app_number] => 13/836256
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9239
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13836256
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/836256 | System and method for determining risk of diabetes based on biochemical marker analysis | Mar 14, 2013 | Issued |
Array
(
[id] => 9737306
[patent_doc_number] => 20140273025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'SYSTEM AND METHOD FOR DETERMINING RISK OF PRE-ECLAMPSIA BASED ON BIOCHEMICAL MARKER ANALYSIS'
[patent_app_type] => utility
[patent_app_number] => 13/837134
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9598
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13837134
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/837134 | SYSTEM AND METHOD FOR DETERMINING RISK OF PRE-ECLAMPSIA BASED ON BIOCHEMICAL MARKER ANALYSIS | Mar 14, 2013 | Abandoned |